Topics

1. Overarching Theme Track: “Brains, Bytes & Beyond: Tech in Neurology”

• Artificial Intelligence (AI) and Machine Learning in Neurological Diagnostics and Prognostication

• Digital Biomarkers, Wearable Sensors, and Remote Patient Monitoring in Neurological Diseases

• Brain-Computer Interfaces (BCIs), Neuroprosthetics, and Closed-Loop Neuromodulation

• Big Data, Computational Neuroscience, and Precision Medicine in Neurology

• Telemedicine, Telestroke Networks, and Virtual Care Models in Clinical Practice

• Ethical, Legal, and Regulatory Challenges of AI and Emerging Neurotechnologies

2. Cerebrovascular Diseases & Stroke

• Hyperacute Management of Acute Ischemic Stroke: Intravenous Thrombolysis and Mechanical Thrombectomy

• Neuroimaging Selection in Extended Time Windows and Large Core Infarcts

• Intracerebral Hemorrhage (ICH) and Subarachnoid Hemorrhage: Acute Blood Pressure Control, Hemostatic Therapy, and Minimally Invasive Surgery

• Cerebral Small Vessel Disease, Vascular Cognitive Impairment, and Cerebral Amyloid Angiopathy

• Secondary Stroke Prevention: Antithrombotic Strategies, Patent Foramen Ovale (PFO) Closure, and Carotid Stenosis Management

• Stroke in Young Adults, Rare Causes of Stroke, and Cerebral Venous Sinus Thrombosis (CVST)

3. Movement Disorders

• Parkinson’s Disease: Prodromal Markers, Alpha-Synuclein Seed Amplification Assays, and Disease-Modifying Trials

• Device-Aided Therapies in Advanced Parkinson’s Disease: Adaptive Deep Brain Stimulation (aDBS), Focused Ultrasound, and Continuous Subcutaneous Infusions

• Atypical Parkinsonian Syndromes: Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), and Corticobasal Degeneration (CBD)

• Hyperkinetic Movement Disorders: Essential Tremor, Dystonia, Huntington’s Disease, Chorea, Myoclonus, and Tics

• Functional Movement Disorders: Positive Diagnostic Signs and Multidisciplinary Rehabilitation

4. Dementia, Cognitive & Behavioral Neurology

• Alzheimer’s Disease in the Era of Anti-Amyloid Immunotherapies: Patient Selection, APOE Genotyping, and ARIA Monitoring

• Fluid (Plasma and CSF) and PET Biomarkers for Early Detection of Neurodegeneration

• Frontotemporal Lobar Degeneration (FTLD), Primary Progressive Aphasias, and Dementia with Lewy Bodies (DLB)

• Normal Pressure Hydrocephalus (NPH) and Reversible Causes of Cognitive Decline

• Management of Neuropsychiatric Symptoms and Behavioral Disturbances in Dementia

5. Multiple Sclerosis & Neuroimmunology

• Evolving Diagnostic Criteria (McDonald Criteria Updates) and Early High-Efficacy Treatment in Multiple Sclerosis

• Smoldering MS, Progression Independent of Relapse Activity (PIRA), and BTK Inhibitors

• Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD): Diagnostic Pitfalls and Targeted Biologics

• Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes

• Neurosarcoidosis, CNS Vasculitis, and Neurological Complications of Immune Checkpoint Inhibitors

6. Epilepsy & Clinical Neurophysiology

• Classification and Medical Management of Focal, Generalized, and Developmental and Epileptic Encephalopathies (DEEs)

• First Seizure Evaluation, Seizure Mimics, and Psychogenic Non-Epileptic Seizures (PNES)

• Diagnosis and Protocol-Driven Management of Refractory and Super-Refractory Status Epilepticus

• Presurgical Evaluation, Stereo-EEG (sEEG), Epilepsy Surgery, and Neurostimulation (VNS, RNS, DBS)

• Women with Epilepsy: Teratogenicity, Contraception, and Antiseizure Medication Management in Pregnancy

• Quantitative EEG, Automated Seizure Detection, and Long-Term Video-EEG Monitoring

7. Headache & Pain Disorders

• Pathophysiology and Personalized Treatment of Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans

• Medication-Overuse Headache and Chronic Migraine Management Strategies

• Trigeminal Autonomic Cephalalgias (Cluster Headache, Paroxysmal Hemicrania, SUNCT/SUNA)

• Secondary Headache Red Flags, Idiopathic Intracranial Hypertension (IIH), and Spontaneous Intracranial Hypotension (SIH)

• Trigeminal Neuralgia, Cranial Neuralgias, and Central/Peripheral Neuropathic Pain Syndromes

8. Neuromuscular Disorders, Muscle & NMJ Diseases

• Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Diseases: Genetic Testing, Antisense Oligonucleotides, and Multidisciplinary Care

• Immune-Mediated Neuropathies: Guillain-Barré Syndrome (GBS), CIDP, and Autoimmune Nodopathies

• Hereditary Neuropathies (Charcot-Marie-Tooth Disease) and Transthyretin Familial Amyloid Polyneuropathy (hATTR-PN)

• Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: FcRn Antagonists and Complement Inhibitors

• Inherited Myopathies, Muscular Dystrophies, Channelopathies, and Idiopathic Inflammatory Myopathies (Dermatomyositis, Antisynthetase Syndrome, IMNM, IBM)

9. Sleep-Wake Disorders

• REM Sleep Behavior Disorder (RBD) as a Prodrome of Synucleinopathies

• Narcolepsy and Central Disorders of Hypersomnolence: Orexin Agonists and Current Pharmacotherapy

• Restless Legs Syndrome (RLS), Periodic Limb Movement Disorder, and Circadian Rhythm Sleep-Wake Disorders

• Sleep-Related Breathing Disorders and Nocturnal Epilepsy

10. Neurocritical Care, Coma & Disorders of Consciousness

• Multimodal Neuromonitoring and Management of Intracranial Hypertension and Traumatic Brain Injury (TBI)

• Diagnosis, Prognostication, and Neurorehabilitation of Coma and Prolonged Disorders of Consciousness (UWS, MCS, Cognitive Motor Dissociation)

• Neurological Prognostication After Cardiac Arrest and Hypoxic-Ischemic Brain Injury

• Determination of Brain Death / Death by Neurologic Criteria (DNC)

11. Neuro-Oncology, Neuro-Infectious Diseases & Neurogenetics

• Molecular Classification and Targeted Therapy of Gliomas, CNS Lymphomas, and Brain Metastases

• Neurological Complications of Systemic Cancer, CAR-T Cell Therapy (ICANS), and Radiation Necrosis

• Acute Bacterial, Viral, Fungal, and Tuberculous Meningitis and Encephalitis

• Neuroborreliosis, Neurosyphilis, HIV-Associated Neurocognitive Disorders, and Emerging Neurotropic Infections

• Next-Generation Sequencing (NGS), Repeat Expansion Disorders, Hereditary Spastic Paraplegias, Spinocerebellar Ataxias, and Gene Therapies in Neurology

12. Autonomic Nervous System, Neuro-Ophthalmology, Neuro-Otology & Neurorehabilitation

• Evaluation and Management of Neurogenic Orthostatic Hypotension, Postural Orthostatic Tachycardia Syndrome (POTS), and Autonomic Failure

• Acute Vestibular Syndrome, Episodic Vertigo (BPPV, Vestibular Migraine, Meniere’s Disease), and Eye Movement Disorders

• Optic Neuritis, Ischemic Optic Neuropathies, and Diplopia Workup

• Robotics, Non-Invasive Brain Stimulation (TMS, tDCS), Virtual Reality, and Spasticity Management in Neurorehabilitation

• Palliative Care, Advance Care Planning, and End-of-Life Decision-Making in Severe Neurological Illness